Boardroom Alpha
Meeting calendar
RBB · Annual meeting · Thursday, May 21, 2026

Rbb Bancorp

9 nominees · 3 ballot items.

Election of nine directors; advisory approval of Named Executive Officers’ compensation (Say-on-Pay); ratification of Crowe LLP as independent auditor; and transacting other business as may properly come before the Annual Meeting.

Market cap
$462M
1Y TSR
+47.2%
Board grade
C
Record date
Mar 24, 2026
Filing
DEF 14A
Meeting concluded · May 21, 2026

Follow how the vote landed and what changed on Rbb Bancorp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect nine (9) directors to serve one-year terms until the next annual meeting.

  2. 2

    Advisory Vote on Named Executive Officers Compensation

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers (Say-on-Pay).

    More detail

    This proposal asks shareholders to cast an advisory (non-binding) vote approving the 2025 compensation of the Company’s Named Executive Officers (NEOs) as disclosed in the proxy statement, including pay elements such as base salary, annual cash incentives, long-term equity awards (RSUs and PRSUs), benefits and severance arrangements. Management seeks shareholder approval primarily to validate its executive compensation design — which emphasizes pay-for-performance through annual cash incentives and long-term equity with performance-based PRSUs tied to rTSR, ROAA and ROATCE — and to demonstrate alignment between management and shareholder interests. The Board highlights a strong governance framework (clawback policies, share ownership, independent compensation committee, and engagement with an external consultant) and notes prior high say-on-pay support (97% in 2025) to justify its recommendation. The proposal is non-binding, so while the Company will consider the vote in future decisions, the Board retains discretion over compensation design and payouts. Key context includes recent executive leadership transitions (appointment of Johnny Lee as CEO in 2025 and retirement of David Morris), a redesigned compensation program with scorecard methodologies for annual incentives, and performance metrics tied to multi-year PRSU awards. The Board’s recommendation to vote FOR is justified by its view that the compensation program aligns with long-term strategy, shareholder value creation, and market practices; however, because the vote is advisory and shareholders lack direct enforcement rights, institutional investors will weigh pay-for-performance linkage (rTSR and absolute financial metrics), governance features, and retention provisions when forming their vote. The outcome may influence future compensation program adjustments and continued shareholder engagement by the Compensation, Nominating and Governance Committee.

  3. 3

    Ratification of Appointment of Independent Auditors

    ManagementBoard: FOR

    Ratify Crowe LLP as the Company’s independent auditor for fiscal year ending December 31, 2026.

Director elections

Nominees on the ballot9

Not independent
Tenure on this board
1.1 yrs
Independent
Tenure on this board
4.2 yrs
Also a director at
Processa Pharmaceuticals Inc (PCSA)
Ownership

Top institutional holders10

Latest 13F quarter
1FJ Capital Management LLC8.9%1,511,408$32M
2DIMENSIONAL FUND ADVISORS LP4.7%799,233$17M
3VANGUARD CAPITAL MANAGEMENT LLC3.9%660,025$14M
4BlackRock, Inc.3.6%616,756$13M
5AMERICAN CENTURY COMPANIES INC2.8%467,678$10M
6BlackRock, Inc.2.4%412,098$9M
7ALLIANCEBERNSTEIN L.P.2.3%382,318$8M
8Rhino Investment Partners, Inc2.0%338,810$7M
9STATE STREET CORP1.9%324,822$7M
10GEODE CAPITAL MANAGEMENT, LLC1.8%298,528$6M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Rbb Bancorp 2026 annual meeting?
Rbb Bancorp (RBB) holds its 2026 annual shareholder meeting on Thursday, May 21, 2026.
What is the record date for the Rbb Bancorp 2026 meeting?
The record date for the Rbb Bancorp 2026 meeting is Tuesday, March 24, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Rbb Bancorp's 2026 meeting?
The board is presenting 9 director nominees at the Rbb Bancorp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Rbb Bancorp 2026 meeting?
Shareholders will vote on 3 proposals at the Rbb Bancorp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer